Nrxn3は筋筋膜性侵害受容性疼痛を軽減する
Lauren Nguyen1, Mikhail Umorin1, Phillip R Kramer1
1Department of Biomedical Sciences, Texas A&M University College of Dentistry, Dallas, TX 75246, United States.
Neurobiology of pain (Cambridge, Mass.)
|December 30, 2025
まとめ
脳内の神経線維受容体3(Nrxn3)
科学分野:
- 神経科学
- 疼痛研究
- 分子生物学
背景:
- 神経線維受容体3(Nrxn3)は神経シグナル伝達において役割を果たす。
- 中枢扁桃体におけるNrxn3発現の低下は、顔面口腔神経障害性疼痛の増加と関連している。
- 筋筋膜性疼痛は一般的な顎関節障害である。
研究 の 目的:
- 筋筋膜性疼痛におけるNrxn3の役割を調査する。
- Nrxn3が筋筋膜性過敏性を軽減するという仮説を検証する。
主な方法:
- 雄ラットの中枢扁桃体にNrxn3 shRNAを注入した。
- 咀嚼筋腱結紮により炎症性顔面口腔痛を誘発した。
- 暗期摂食時間およびフォン・フレイ・フィラメント試験を用いて疼痛反応を測定した。
- 主要な疼痛経路領域におけるc-Fos染色を用いて神経活動を評価した。
主要な成果:
- 中枢扁桃体におけるNrxn3のノックダウンは、顔面口腔痛反応を著しく増加させた。
- 神経活動の増加(c-Fosレベル)が顔面口腔痛経路で観察された。
- 増強された疼痛反応および神経活動は、2週間以上にわたって持続した。
結論:
- 中枢扁桃体におけるNrxn3の発現は、侵害受容性顔面口腔痛を減弱させる。
- Nrxn3は、顔面口腔痛経路における神経活動を減少させることによって疼痛を軽減する可能性が高い。
さらに関連する動画
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
2.6K
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
9.2K
関連する概念動画
Nociception
32.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.9K
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.3K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872
Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
